Functional interactors of three genome-wide association study genes are differentially expressed in severe chronic obstructive pulmonary disease lung tissue

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Morrow, Jarrett D ^a   Zhou, Xiaobo ^a   Lao, Taotao ^a   Jiang, Zhiqiang ^a   Demeo, Dawn L ^a   Cho, Michael H ^a   Qiu, Weiliang ^a   Cloonan, Suzanne ^b   Pinto Plata, Victor ^c   Celli, Bartholome ^a   Marchetti, Nathaniel ^d   Criner, Gerard J ^d   Bueno, Raphael ^a   Washko, George R ^a   Glass, Kimberly ^a   Quackenbush, John ^e   Choi, Augustine M K ^b   Silverman, Edwin K ^a   Hersh, Craig P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; LUNG; MALE; METABOLISM; MIDDLE AGED; MOUSE; MULTICENTER STUDY; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANIMALS; FEMALE; GENE EXPRESSION REGULATION; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG; MALE; MICE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 85015256278     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep44232     Document Type: Article

References (80)

1. Vestbo,J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 187, 347-65 (2013).
2. Hersh, C. P. et al. Family history is a risk factor for COPD. Chest 140, 343-350 (2011).
3. McCloskey, S. et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 164, 1419-1424 (2001).
4. Silverman, E. K. In Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment (eds. Organizer, D. C. & Goode, J. A.) 45-64 (John Wiley & Sons, Ltd, 2000).
5. Silverman, E. K. et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am. J. Respir. Crit. Care Med. 157, 1770-8 (1998).
6. Cho, M. H. et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat. Genet. 42, 200-202 (2010).
7. Cho, M. H. et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum. Mol. Genet. 21, 947-57 (2012).
8. Cho, M. H. et al. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir. Med. 2, 214-25 (2014).
9. Bhattacharya, S. et al. Molecular Biomarkers for Quantitative and Discrete COPD Phenotypes. Am. J. Respir. Cell Mol. Biol. 40, 359-367 (2009).
10. Campbell, J. D. et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 4, 67 (2012).
11. Ezzie, M. E. et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 67, 122-131 (2012).
12. Francis, S. M. et al. Expression profiling identifies genes involved in emphysema severity. Respir. Res. 10, 81 (2009).
13. Golpon, H. A. et al. Emphysema Lung Tissue Gene Expression Profiling. Am. J. Respir. Cell Mol. Biol. 31, 595-600 (2004).
14. Ning, W. et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc. Natl. Acad. Sci. USA 101, 14895-14900 (2004).
15. Savarimuthu Francis, S. M. et al. Genes and Gene Ontologies Common to Airflow Obstruction and Emphysema in the Lungs of Patients with COPD. PLoS ONE 6, e17442 (2011).
16. Spira, A. et al. Gene Expression Profiling of Human Lung Tissue from Smokers with Severe Emphysema. Am. J. Respir. Cell Mol. Biol. 31, 601-610 (2004).
17. Wang, I.-M. et al. Gene Expression Profiling in Patients with Chronic Obstructive Pulmonary Disease and Lung Cancer. Am. J. Respir. Crit. Care Med. 177, 402-411 (2008).
18. Zeskind, J. E., Lenburg, M. E. & Spira, A. Translating the COPD Transcriptome. Proc. Am. Thorac. Soc. 5, 834-841 (2008).
19. Chen, Z.-H., Kim, H. P., Ryter, S. W. & Choi, A. M. Identifying targets for COPD treatment through gene expression analyses. Int. J. Chron. Obstruct. Pulmon. Dis. 3, 359 (2008).
20. Hobbs, B. D. & Hersh, C. P. Integrative genomics of chronic obstructive pulmonary disease. Biochem. Biophys. Res. Commun. 452, 276-286 (2014).
21. Huan, T. et al. A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 33, 1427-1434 (2013).
22. Lui, J. C. et al. Synthesizing genome-wide association studies and expression microarray reveals novel genes that act in the human growth plate to modulate height. Hum. Mol. Genet. 21, 5193-5201 (2012).
23. Taneera, J. et al. A Systems Genetics Approach Identifies Genes and Pathways for Type 2 Diabetes in Human Islets. Cell Metab. 16, 122-134 (2012).
24. Voineagu, I. et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380-384 (2011).
25. Maurano, M. T. et al. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA. Science 337, 1190-1195 (2012).
26. Murphy, A. et al. Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes. Hum. Mol. Genet. 19, 4745-4757 (2010).
27. Nicolae, D. L. et al. Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS. PLoS Genet 6, e1000888 (2010).
28. Obeidat, M. et al. Molecular mechanisms underlying variations in lung function: a systems genetics analysis. Lancet Respir. Med. 3, 782-795 (2015).
29. Cloonan, S. et al. Mitochondrial iron as a therapeutic target for IRP2-regulated cigarette smoke-induced bronchitis and emphysema. Nat. Med. 22, 163-74 (2016)
30. Jiang, Z. et al. A Chronic Obstructive Pulmonary Disease Susceptibility Gene, FAM13A, Regulates Protein Stability of β -catenin. Am. J. Respir. Crit. Care Med 194, 185-97 (2016).
31. Zhou, X. et al. Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. Genomics 101, 263-272 (2013).
32. Lao, T. et al. Haploinsufficiency of Hedgehog interacting protein causes increased emphysema induced by cigarette smoke through network rewiring. Genome Med. 7, 12 (2015).
33. Haas, B. E. et al. Adipose co-expression networks across Finns and Mexicans identify novel triglyceride-associated genes. BMC Med. Genomics 5 (2012).
34. Silverman, E. & Loscalzo, J. Network Medicine Approaches to the Genetics of Complex Diseases. Discov. Med. 14, 143-152 (2012).
35. Morrow, J. D. et al. Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods. BMC Med. Genomics 8, 1 (2015).
36. Xue, J. et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274-88 (2014).
37. Ferhani, N. et al. Expression of High-Mobility Group Box 1 and of Receptor for Advanced Glycation End Products in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 181, 917-927 (2010).
38. Cheng, D. T. et al. Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 188, 948-957 (2013).
39. Cho, M. H. et al. A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes. Am. J. Respir. Crit. Care Med. 192, 559-569 (2015).
40. Manichaikul, A. et al. Genome-Wide Study of Percent Emphysema on Computed Tomography in the General Population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am. J. Respir. Crit. Care Med. 189, 408-418 (2014).
41. Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R. & Pfister, H. UpSet: Visualization of Intersecting Sets. IEEE Trans. Vis. Comput. Graph. 20, 1983-1992 (2014).
42. Horvath, S. Weighted Network Analysis. (Springer New York, 2011).
43. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
44. Faner, R. et al. Network Analysis of Lung Transcriptomics Reveals a Distinct B Cell Signature in Emphysema. Am. J. Respir. Crit. Care Med. 193, 1242-53 (2016).
45. Repapi, E. et al. Genome-wide association study identifies five loci associated with lung function. Nat. Genet. 42, 36-44 (2010).
46. Zhang, Y. et al. Changes of HMGB1 and sRAGE during the recovery of COPD exacerbation. J. Thorac. Dis. 6, 734 (2014).
47. Ko, H.-K. et al. High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers. Respirology 19, 253-261 (2014).
48. Hou, C. et al. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol. Med. 17, 807 (2011).
49. Pouwels, S. D. et al. DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunol. 7, 215-226 (2014).
50. Mizumura, K. et al. Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J. Clin. Invest. 124, 3987-4003 (2014).
51. DeMeo, D. L. et al. The SERPINE2 Gene Is Associated with Chronic Obstructive Pulmonary Disease. Am. J. Hum. Genet. 78, 253-264 (2006).
52. Himes, B. E. et al. Association of SERPINE2 with asthma. Chest. 140, 667-674 (2011).
53. Hodge, S., Hodge, G., Holmes, M. & Reynolds, P. N. Increased peripheral blood T-cell apoptosis and decreased Bcl-2 in chronic obstructive pulmonary disease. Immunol. Cell Biol. 83, 160-166 (2005).
54. Siganaki, M. et al. Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients. Respir. Res. 11, 46 (2010).
55. Zeng, H. et al. Apoptosis and Bcl-2 family proteins, taken to chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci 16, 711-727 (2012).
56. Baraldo, S. et al. Immune Activation in α 1 -Antitrypsin-Deficiency Emphysema. Beyond the Protease-Antiprotease Paradigm. Am. J. Respir. Crit. Care Med. 191, 402-409 (2015).
57. Brusselle, G. G., Demoor, T., Bracke, K. R., Brandsma, C.-A. & Timens, W. Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur. Respir. J. 34, 219-230 (2009).
58. Faner, R., Cruz, T. & Agusti, A. Immune response in chronic obstructive pulmonary disease. Expert Rev. Clin. Immunol. 9, 821-833 (2013).
59. Hogg, J. C. et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653 (2004).
60. Polverino, F. et al. B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 192, 695-705 (2015).
61. van der Strate, B. W. A. et al. Cigarette Smoke-induced Emphysema: A Role for the B Cell? Am. J. Respir. Crit. Care Med. 173, 751-758 (2006).
62. Liu, P. et al. Bcl11a is essential for normal lymphoid development. Nat. Immunol. 4, 525-532 (2003).
63. Singh, H., Medina, K. L. & Pongubala, J. M. R. Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA. 102, 4949-4953 (2005).
64. Durham, A. L. et al. Regulation of Wnt4 in chronic obstructive pulmonary disease. FASEB J. 27, 2367-2381 (2013).
65. Tilley, A. E. et al. Biologic Phenotyping of the Human Small Airway Epithelial Response to Cigarette Smoking. PLoS ONE 6, e22798 (2011).
66. Teitell, M. A. OCA-B regulation of B-cell development and function. Trends Immunol. 24, 546-553 (2003).
67. Goh, K.-I. et al. The human disease network. Proc. Natl. Acad. Sci. 104, 8685-8690 (2007).
68. Hao, K. et al. Lung eQTLs to Help Reveal the Molecular Underpinnings of Asthma. PLOS Genet 8, e1003029 (2012).
69. Nakano, Y. et al. The Prediction of Small Airway Dimensions Using Computed Tomography. Am. J. Respir. Crit. Care Med. 171, 142-146 (2005).
70. Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008).
71. Lao, T. et al. Hhip haploinsufficiency sensitizes mice to age-related emphysema. Proc. Natl. Acad. Sci. 113, E4681-E4687 (2016).
72. Heinz, S. et al. Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities. Mol. Cell 38, 576-589 (2010).
73. Chuang, P.-T., Kawcak, T. & McMahon, A. P. Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev. 17, 342-347 (2003).
74. Leek, J. T. & Storey, J. D. Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis. PLoS Genet 3, e161 (2007).
75. Smyth, G. K. In Bioinformatics and Computational Biology Solutions Using {R} and Bioconductor (eds Gentleman, R., Carey, V., Dudoit, S., Irizarry, R. & Huber, W.) 397-420 (Springer, 2005).
76. Feng, G. et al. A collection of bioconductor methods to visualize gene-list annotations. BMC Res. Notes 3, 10-10 (2010).
77. Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, 7 (2015).
78. Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867-2873 (2010).
79. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
80. Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353-1358 (2012).